Health care stocks were rising Friday afternoon, with the NYSE Health Care Index adding 0.8% and the Health Care Select Sector SPDR Fund (XLV) up 0.3%.
The iShares Biotechnology ETF (IBB) eased 0.3%.
In corporate news, Novo Nordisk (NVO) shares jumped 8.2% after it said Friday that its investigative weight loss drug amycretin led to a body weight reduction of up to 22% in an early-stage trial.
HCA Healthcare (HCA) reported Q4 adjusted earnings Friday of $6.22 per diluted share, up from $5.90 a year earlier. Revenue for the quarter was $18.29 billion, up from $17.30 billion a year earlier. Its shares were shedding 3.5%.
Allurion Technologies (ALUR) shares surged past 122%. The company said Friday that it signed a definitive agreement with institutional investors for the sale of 1.24 million common shares at $6 per share through a registered direct offering for proceeds of $7.4 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.